benitec.com - BNTC Earnings growth forecast for next year
Benitec Biopharma Inc. (BNTC) competes in the DNA silencing niche, leveraging the uniqueness of the BB-301 system. Research centers in the US and Australia focus on treating genetic pathologies, while the strategy is based on completing trials for a muscular dystrophy drug. This chart, provided by the GURU.Markets platform, shows that the projection of the company's EPS for the next year demonstrates the fresh parameter -22.20.
Benitec Biopharma (BNTC) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- debt and solvency information:
- earnings and valuation multiples information:
BNTC - Net Income|Projected Future Earnings Benitec Biopharma Inc.|BNTC - P/E Multiple|Projected Price to Earnings Benitec Biopharma|BNTC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Benitec Corp|BNTC - Operating income before deduction of amortization|Earnings per share for the last twelve months Benitec Biopharma|BNTC - Earnings per share for the last 12 months|Quarterly EPS earnings growth benitec.com|BNTC - Net earnings per share growth this year|Expected earnings per share growth for next year Benitec Biopharma Inc.
- revenue and sales details:
Fundamental company valuation:Benitec Corp, BNTC
Benitec Biopharma Inc. (BNTC) gene therapy development is independent of macroeconomic cycles and GDP, relying exclusively on medical research results. The projected net income growth rate per share reflects the analysts' consensus estimate regarding the future profitability of the business. This indicator measures the expected percentage change in EPS, allowing for the differentiation of fundamental growth from speculative overheating. Such securities belong to a high-risk asset class with potential for exponential growth.
Main competitors
TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Expected earnings per share trend next year RARE (ultragenyx.com)|BEAM: Earnings growth forecast for next year|Sarepta - Expected earnings per share trend next year|TWST (twistbioscience.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year TXG (10x Genomics Corp)|Earnings growth forecast for next year NTLA|Earnings growth forecast for next year Stoke Therapeutics, Inc. (STOK)|Net earnings per share growth forecast for next year BioLife BLFS|WVE - Expected earnings per share growth for next year|Maze Therapeutics Corp - Earnings growth forecast for next year|Sionna Pharma - Projected earnings per share increase next year|Prime Medicine (PRME) - Net earnings per share growth forecast for next year|tayshagtx.com (TSHA) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year uniQure Corp|MGTX: Expected earnings per share trend next year|Earnings growth forecast for next year RGNX|Consensus forecast of earnings per share growth for next year Solid Corp|Earnings growth forecast for next year OCGN (ocugen.com)|PACB (Pacific Biosciences) - Net earnings per share change forecast for next year|DSGN - Net earnings per share growth forecast for next year|RCKT: Net earnings per share growth forecast for next year|FDMT - Projected earnings per share increase next year|Expected net earnings per share growth next year Lexeo Therapeutics Inc. (LXEO)|Net earnings per share growth forecast for next year Korro Bio Inc.|Editas Medicine (EDIT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Silence Therapeutics Inc. (SLN)|PRQR: Net earnings per share change forecast for next year|Earnings growth forecast for next year CDXS (codexis.com)|SGMO: Projected earnings per share growth rate for next year|NAUT: Expected earnings per share growth for next year|Expected net earnings per share growth next year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Generation Bio Corp (GBIO)|Expected earnings per share growth for next year BOLD|exicuretx.com (XCUR) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Expected earnings per share trend next year|Earnings growth forecast for next year MBIO (Mustang Bio Corp)|Projected earnings per share increase next year RNAZ (TransCode Therapeutics)|BNGO - Net earnings per share growth forecast for next year|APDN: Net earnings per share growth forecast for next year|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year
